Strategic Services for European Pharmaceutical Market Entry
NCB Consulting specializes in European pharma market entry and launch excellence with particular depth in DACH and France. Our work is structured around five core service areas, delivering strategic intelligence that informs your launch decisions.
WHAT WE DO VS DON'T DO
What NCB Consulting DOES:
Strategic intelligence that INFORMS market access decisions
Patient journey insights and competitive positioning
Value story development and commercial strategy
Launch readiness analysis and positioning frameworks
Competitive intelligence and market opportunity assessment
What NCB Consulting DOES NOT DO:
Market access execution (pricing dossiers, reimbursement submissions)
Payer negotiations or HTA dossier preparation
AMNOG, HAS, NICE, AIFA submission execution
Traditional market research (surveys, focus groups)
Clinical trial design or regulatory affairs